Key result
AKAP9 or KCNQ1 mutations blunt sympathetic potassium channel enhancement in LQTS by impairing PKA phosphorylation.
Why the study?
While ion channel mutations are known causes of inherited long QT syndrome, the role of regulatory proteins like a-kinase anchoring protein 9 in modulating channel function remains an area of emerging evidence.
AKAP9 mutations contribute to long QT syndrome by disrupting the macromolecular complex required for β-adrenergic modulation of potassium channels.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) conducted a review in Long QT syndrome (LQTS). AKAP9 mutations (e.g., S1570L) was evaluated. Mutations in AKAP9 or KCNQ1 destabilize their macromolecular complex, impairing PKA-mediated phosphorylation and blunting sympathetic enhancement of potassium channels in long QT syndrome.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: